The Albuterol shortage is worsening
With February’s sudden shutdown of an Illinois manufacturing plant, STAQ’s production of Albuterol may be in even higher demand, according to a recent article by The Washington Post.
Addressing the pediatric albuterol shortage
Albuterol — one of the most essential medications for pediatric patients — has been facing a critical shortage since June 2022. In partnership with Children’s Hospital Colorado (CHC), STAQ has been able to supply and maintain continuous albuterol for children’s hospitals. STAQ is committed to getting pediatric hospitals through this respiratory season and helping to
STAQ Partners with FDA and Children’s Hospital Association to Address Albuterol Shortage
Being able to make a positive impact on the critical Albuterol shortage is one of the reasons we got into this business. The “A” in STAQ stands for availability, after all.